Format

Send to

Choose Destination
Liver Int. 2017 Feb;37(2):308-309. doi: 10.1111/liv.13278.

Response to Is radiotherapy the best option for treating hepatocellular carcinoma with PVTT?

Author information

1
Department of Radiation Oncology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
2
Department of Radiation Oncology, Asan Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
3
Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
4
Department of Medical Device Management and Research, SAIHST, Sungkyunkwan University, Seoul, Korea.
5
Center for Liver Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
6
Department of Radiation Oncology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
7
Department of Radiation Oncology, Chonnam National University Medical School, Gwangju, Korea.
8
Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.
9
Department of Radiation Oncology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.
10
Department of Radiation Oncology, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Korea.
11
Department of Radiation Oncology, Korea Institute Radiological & Medical Sciences, Seoul, Korea.
12
Department of Radiation Oncology, Ansan Hospital, Korea University Medical Center, Ansan, Korea.
13
Department of Biostatistics, Yonsei University College of Medicine, Seoul, Korea.
PMID:
28070983
DOI:
10.1111/liv.13278
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center